LNP Editing Preserves Stem Cell Yield in Sickle-Cell Models

Institution: Innovative Genomics Institute · Technology: Lipid Nanoparticle CRISPR Delivery vs. Electroporation · Target: Erythroid BCL11A Enhancer · Application: Sickle Cell Disease · Date: August 30, 2026 Summary A non-peer-reviewed study directly compared Cas9 ribonucleoprotein electroporation with lipid-nanoparticle delivery of Cas9 messenger RNA to disrupt…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *